UiPath (NYSE:PATH) Trading Down 0.4%

UiPath Inc. (NYSE:PATH)’s stock price was down 0.4% during trading on Friday . The company traded as low as $18.79 and last traded at $18.97. Approximately 1,170,693 shares changed hands during trading, a decline of 87% from the average daily volume of 8,853,152 shares. The stock had previously closed at $19.04.

Analyst Ratings Changes

A number of equities research analysts have recently commented on PATH shares. Scotiabank increased their price target on shares of UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a report on Thursday, March 14th. Royal Bank of Canada restated a “sector perform” rating and set a $29.00 price objective on shares of UiPath in a research report on Monday, April 1st. BMO Capital Markets increased their price objective on shares of UiPath from $24.00 to $28.00 and gave the company a “market perform” rating in a research report on Thursday, March 14th. TD Cowen increased their price objective on shares of UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, March 14th. Finally, Evercore ISI increased their price objective on shares of UiPath from $24.00 to $27.00 and gave the company an “in-line” rating in a research report on Thursday, March 14th. Nine research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $27.41.

UiPath Price Performance

The firm has a market capitalization of $10.67 billion, a P/E ratio of -110.29 and a beta of 0.96. The company’s 50-day simple moving average is $22.82 and its two-hundred day simple moving average is $21.49.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.10. The firm had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. Analysts predict that UiPath Inc. will post -0.04 earnings per share for the current year.

Insider Activity

In other news, CFO Ashim Gupta sold 16,000 shares of the firm’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the sale, the chief financial officer now directly owns 87,505 shares in the company, valued at approximately $1,998,614.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 72,000 shares of company stock worth $1,591,360 in the last three months. Company insiders own 31.03% of the company’s stock.

Institutional Trading of UiPath

Institutional investors and hedge funds have recently modified their holdings of the company. Kovack Advisors Inc. purchased a new position in UiPath during the first quarter valued at $220,000. Graphene Investments SAS grew its stake in UiPath by 24.9% during the first quarter. Graphene Investments SAS now owns 129,300 shares of the healthcare company’s stock valued at $2,931,000 after acquiring an additional 25,800 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in UiPath by 819.5% during the first quarter. Allspring Global Investments Holdings LLC now owns 19,209 shares of the healthcare company’s stock valued at $435,000 after acquiring an additional 17,120 shares in the last quarter. Diversified Trust Co purchased a new position in UiPath during the first quarter valued at $553,000. Finally, SteelPeak Wealth LLC grew its stake in UiPath by 46.3% during the first quarter. SteelPeak Wealth LLC now owns 22,592 shares of the healthcare company’s stock valued at $512,000 after acquiring an additional 7,149 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.